The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Uric Acid and the Risks of Kidney Failure and Death in Individuals With CKD
Open accessAbstract
Background Plasma uric acid levels rise in chronic kidney disease (CKD) and may lead to tubular injury, endothelial dysfunction, oxidative stress, and intra-renal inflammation. Whether uric acid levels are associated with kidney failure and death in CKD is unknown. Study Design A prospective, observational, cohort study. Settings & Participants 3885 individuals with CKD stages 2–4 enrolled in the Chronic Renal Insufficiency Cohort (CRIC) between June 2003 and September 2008, and followed up through March 2013. Predictor Baseline serum uric acid levels. Outcomes Kidney failure (initiation of dialysis or transplantation) and all-cause mortality. Results During a median follow-up of 7.9 years, 885 participants progressed to kidney failure, and 789 participants died. After adjustment for demographic, cardiovascular, and kidney-specific covariates, higher levels of uric acid were independently associated with risk of kidney failure in participants with an estimated glomerular filtration rate ≥ 45 mL/min/1.73 m2 (adjusted HR per 1–standard deviation [SD] greater baseline uric acid, 1.40; 95% CI, 1.12–1.75), but not in those with eGFR < 30 mL/min/1.73 m2. There was a nominally higher HR in participants with an eGFR of 30–44 (adjusted HR, 1.13; 95% CI, 0.99–1.29), but this did not reach statistical significance. The relationship between uric acid and all-cause mortality was J-shaped (P = 0.007). Limitations Potential residual confounding through unavailable confounders; lack of follow-up measurements to adjust for changes in uric acid levels over time. Conclusions Uric acid is an independent risk factor for kidney failure in earlier stages of CKD, and has a ‘J-shaped’ relationship with all-cause mortality in CKD. Adequately powered randomized, placebo-controlled trials in CKD are needed to test whether urate lowering may prove to be an effective approach to prevent complications and progression of CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A New Equation to Estimate Glomerular Filtration Rate
Levey, A. S., Stevens, L. A., Schmid, C. H., Zhang, Y. (., Castro, A. F., Feldman, H. I., Kusek, J. W., Eggers, P., Van Lente, F., Greene, T., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-9-200905050-00006 · Cited by 25,603
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Ames, B. N., Cathcart, R., Schwiers, E., & Hochstein, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.11.6858 · Cited by 2,909
Uric Acid and Cardiovascular Risk
Feig, D. I., Kang, D.-H., & Johnson, R. J. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800885 · Cited by 2,440
Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
Mazzali, M., Hughes, J., Kim, Y.-G., Jefferson, J. A., Kang, D.-H., Gordon, K. L., Lan, H. Y., Kivlighn, S., & Johnson, R. J. (2001) · Hypertension · doi:10.1161/hy1101.092839 · Cited by 1,300
Howard, S. C., Jones, D. P., & Pui, C.-H. (2011) · New England Journal of Medicine · doi:10.1056/nejmra0904569 · Cited by 1,044
Siu, Y.-P., Leung, K.-T., Tong, M. K.-H., & Kwan, T.-H. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.006 · Cited by 834
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Goicoechea, M., de Vinuesa, S. G., Verdalles, U., Ruiz-Caro, C., Ampuero, J., Rincón, A., Arroyo, D., & Luño, J. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.01580210 · Cited by 834
Corry, D. B., Eslami, P., Yamamoto, K., Nyby, M. D., Makino, H., & Tuck, M. L. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282f240bf · Cited by 751
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods
Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Cizman, B., Daugirdas, J., Fink, J. C., Franklin-Becker, E. D., Go, A. S., Hamm, L. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070149.78399.ce · Cited by 659
Uric acid and chronic kidney disease: which is chasing which?
Johnson, R. J., Nakagawa, T., Jalal, D., Sanchez-Lozada, L. G., Kang, D.-H., & Ritz, E. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft029 · Cited by 654
Yu, M.-A., Sánchez-Lozada, L. G., Johnson, R. J., & Kang, D.-H. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328337da1d · Cited by 626
Lash, J. P., Go, A. S., Appel, L. J., He, J., Ojo, A., Rahman, M., Townsend, R. R., Xie, D., Cifelli, D., Cohan, J., et al. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00070109 · Cited by 619
Uric Acid Is a Risk Factor for Myocardial Infarction and Stroke: The Rotterdam Study
Bos, M. J., Koudstaal, P. J., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2006) · Stroke · doi:10.1161/01.str.0000221716.55088.d4 · Cited by 615
Risk Factors for End-Stage Renal Disease: 25-Year Follow-up
Hsu, C.-Y., Iribarren, C., McCulloch, C. E., Darbinian, J., & Go, A. S. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.605 · Cited by 589
Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid
Davies, K. J. A., Sevanian, A., Muakkassah-Kelly, S. F., & Hochstein, P. (1986) · Biochemical Journal · doi:10.1042/bj2350747 · Cited by 558
Sanchez-Lozada, L. G., Tapia, E., Santamaria, J., Avila-Casado, C., Soto, V., Nepomuceno, T., Rodriguez-Iturbe, B., Johnson, R. J., & Herrera-Acosta, J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00074.x · Cited by 556
Masuo, K., Kawaguchi, H., Mikami, H., Ogihara, T., & Tuck, M. L. (2003) · Hypertension · doi:10.1161/01.hyp.0000091371.53502.d3 · Cited by 516
Uric Acid and Incident Kidney Disease in the Community
Weiner, D. E., Tighiouart, H., Elsayed, E. F., Griffith, J. L., Salem, D. N., & Levey, A. S. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007101075 · Cited by 462
Uric Acid and Long-term Outcomes in CKD
Madero, M., Sarnak, M. J., Wang, X., Greene, T., Beck, G. J., Kusek, J. W., Collins, A. J., Levey, A. S., & Menon, V. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.12.021 · Cited by 436
Relationship of Uric Acid With Progression of Kidney Disease
Chonchol, M., Shlipak, M. G., Katz, R., Sarnak, M. J., Newman, A. B., Siscovick, D. S., Kestenbaum, B., Carney, J. K., & Fried, L. F. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.05.013 · Cited by 420
Nakanishi, N., Okamoto, M., Yoshida, H., Matsuo, Y., Suzuki, K., & Tatara, K. (2003) · European Journal of Epidemiology · doi:10.1023/a:1024600905574 · Cited by 383
Sánchez-Lozada, L. G., Lanaspa, M. A., Cristóbal-García, M., García-Arroyo, F., Soto, V., Cruz-Robles, D., Nakagawa, T., Yu, M. A., Kang, D.-H., & Johnson, R. J. (2012) · Nephron Experimental Nephrology · doi:10.1159/000345509 · Cited by 340
Sircar, D., Chatterjee, S., Waikhom, R., Golay, V., Raychaudhury, A., Chatterjee, S., & Pandey, R. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.05.017 · Cited by 314
Ishani, A., Grandits, G. A., Grimm, R. H., Svendsen, K. H., Collins, A. J., Prineas, R. J., & Neaton, J. D. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005091012 · Cited by 272
Kanbay, M., Huddam, B., Azak, A., Solak, Y., Kadioglu, G. K., Kirbas, I., Duranay, M., Covic, A., & Johnson, R. J. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11451210 · Cited by 248
J-Shaped Mortality Relationship for Uric Acid in CKD
Suliman, M. E., Johnson, R. J., García-López, E., Qureshi, A. R., Molinaei, H., Carrero, J. J., Heimbürger, O., Bárány, P., Axelsson, J., Lindholm, B., et al. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2006.08.019 · Cited by 243
Schwarzschild, M. A., Ascherio, A., Beal, M. F., Cudkowicz, M. E., Curhan, G. C., Hare, J. M., Hooper, D. C., Kieburtz, K. D., Macklin, E. A., Oakes, D., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.5528 · Cited by 243
Uric Acid and Endothelial Dysfunction in Essential Hypertension
Zoccali, C., Maio, R., Mallamaci, F., Sesti, G., & Perticone, F. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005090949 · Cited by 241
Allopurinol Benefits Left Ventricular Mass and Endothelial Dysfunction in Chronic Kidney Disease
Kao, M. P., Ang, D. S., Gandy, S. J., Nadir, M. A., Houston, J. G., Lang, C. C., & Struthers, A. D. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111185 · Cited by 226
Uric Acid Induces Renal Inflammation via Activating Tubular NF-κB Signaling Pathway
Zhou, Y., Fang, L., Jiang, L., Wen, P., Cao, H., He, W., Dai, C., & Yang, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039738 · Cited by 219
Ficociello, L. H., Rosolowsky, E. T., Niewczas, M. A., Maselli, N. J., Weinberg, J. M., Aschengrau, A., Eckfeldt, J. H., Stanton, R. C., Galecki, A. T., Doria, A., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0227 · Cited by 218
Uric Acid, the Metabolic Syndrome, and Renal Disease
Cirillo, P., Sato, W., Reungjui, S., Heinig, M., Gersch, M., Sautin, Y., Nakagawa, T., & Johnson, R. J. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080909 · Cited by 203
Sturm, G., Kollerits, B., Neyer, U., Ritz, E., & Kronenberg, F. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.01.006 · Cited by 170
Maahs, D. M., Caramori, M. L., Cherney, D. Z. I., Gałecki, A. T., Gao, C., Jalal, D. I., Perkins, B. A., Pop‐Busui, R., Rossing, P. R., Mauer, M. S., et al. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0381-0 · Cited by 142
Chronic Renal Insufficiency Cohort Study (CRIC): Overview and Summary of Selected Findings
Denker, M. G., Boyle, S., Anderson, A. H., Appel, L. J., Chen, J., Fink, J. C., Flack, J. M., Go, A. S., Horwitz, E. J., Hsu, C., et al. (2015) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04260415 · Cited by 141
Govindarajulu, U. S., Malloy, E. J., Ganguli, B., Spiegelman, D. L., & Eisen, E. A. (2009) · The International Journal of Biostatistics · doi:10.2202/1557-4679.1104 · Cited by 140
Uric Acid Levels and All-Cause and Cardiovascular Mortality in the Hemodialysis Population
Latif, W., Karaboyas, A., Lin, T., Winchester, J. F., Arrington, C. J., Pisoni, R. L., Marshall, M. R., Kleophas, W., Levin, N. W., Sen, A., et al. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00670111 · Cited by 138
Bhatnagar, V., Richard, E., Wu, W., Nievergelt, C. M., Lipkowitz, M. S., Jeff, J. M., Maihofer, A. X., & Nigám, S. K. (2016) · Clinical Kidney Journal · doi:10.1093/ckj/sfw010 · Cited by 118
Time to target uric acid to retard CKD progression
Kumagai, T., Ota, T., Tamura, Y., Chang, W., Shibata, S., & Uchida, S. (2016) · Clinical and Experimental Nephrology · doi:10.1007/s10157-016-1288-2 · Cited by 99
Vascular Function and Uric Acid-Lowering in Stage 3 CKD
Jalal, D. I., Decker, E., Perrenoud, L., Nowak, K. L., Bispham, N. Z., Mehta, T. H., Smits, G., You, Z., Seals, D. R., Chonchol, M., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016050521 · Cited by 85
Navaneethan, S. D., & Beddhu, S. (2008) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfn621 · Cited by 82
Interaction between uric acid and HMGB1 translocation and release from endothelial cells
Rabadi, M. M., Kuo, M., Ghaly, T., Rabadi, S. M., Weber, M., Goligorsky, M. S., & Ratliff, B. B. (2011) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00520.2011 · Cited by 79
Effect of Urate-lowering Therapies on Renal Disease Progression in Patients with Hyperuricemia
Levy, G. D., Rashid, N., Niu, F., & Cheetham, T. C. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.131159 · Cited by 75
Association of a Polymorphism in a Gene Encoding a Urate Transporter with CKD Progression
Testa, A., Mallamaci, F., Spoto, B., Pisano, A., Sanguedolce, M. C., Tripepi, G. L., Leonardis, D., & Zoccali, C. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11041013 · Cited by 71
The serum uric acid concentration is not causally linked to diabetic nephropathy in type 1 diabetes
Ahola, A. J., Sandholm, N., Forsblom, C. M., Harjutsalo, V., Dahlström, E. H., & Groop, P. (2017) · Kidney International · doi:10.1016/j.kint.2016.11.025 · Cited by 63
Silbernagel, G., Hoffmann, M. M., Grammer, T. B., et al. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.02.008 · Cited by 48
A crystal-clear mechanism of chronic kidney disease
Kurts, C. (2013) · Kidney International · doi:10.1038/ki.2013.251 · Cited by 35
Cited by
Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease
Podkowińska, A., & Formanowicz, D. (2020) · Antioxidants · doi:10.3390/antiox9080752 · Cited by 356
Kammarchedu, V., Butler, D., & Ebrahimi, A. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.340447 · Cited by 79
Metadata
- Authors
- Srivastava, A., Kaze, A. D., McMullan, C. J., Isakova, T., & Waikar, S. S.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 71
- Issue
- 3
- Pages
- 362-370
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2767610685
- Cited by
- 306
- References
- 48
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.